Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

BACKGROUND: A proportion of all immunocompetent patients treated for visceral leishmaniasis (VL) are known to relapse; however, the risk factors for relapse are not well understood. With the support of the Rajendra Memorial Research Institute (RMRI), Médecins Sans Frontières (MSF) implemented a prog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burza, Sakib, Sinha, Prabhat K., Mahajan, Raman, Lima, María Angeles, Mitra, Gaurab, Verma, Neena, Balsegaram, Manica, Das, Pradeep
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3879206/
https://ncbi.nlm.nih.gov/pubmed/24392166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0002536
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados